CHEPLAPHARM Arzneimittel GmbH

Your contact persons

Jens Remmers

Head of Treasury & Investor Relations

Sustainable Governance

Our Corporate Values

Sustainable governance is an important issue for CHEPLAPHARM that we take very seriously. The main focus areas of our corporate governance include having strong compliance systems and supervisory structures as well as a strict anti-bribery and corruption policy: we are unrelenting in our efforts to expand our supervisory and reporting structures to uphold and strengthen public confidence in our Company. 

CHEPLAPHARM has committed itself to the following good practices for the pharmaceutical industry:

  • Good Distribution Practices (GDP)  
  • Good Manufacturing Practices (GMP

"We are aware of our responsibility for sustainability issues – and are working hard to minimise the environmental and social risks in our business." 

CEO Sebastian Braun 

In 2020 we defined and introduced a Code of Conduct in our Company setting out the most important rules and procedures for our employees in the area of compliance. They include protecting intellectual property rights as well as preventing insider dealing and corruption. Moreover, we have set up a whistleblowing system at CHEPLAPHARM for our employees and all those working in our value chain to anonymously report misconduct. This can be done through a 24/7 telephone hotline in German and English or by email.

The survey we conducted among our suppliers showed that all of them have adopted an internal anti-bribery and corruption policy as well as a code of conduct. In addition, 71% said that they have an anonymous whistleblowing system.

In order to optimally meet the continuously growing demands on our company, we have expanded our management board from four to five members. In addition, we have established an external advisory board at CHEPLAPHARM, which monitors the activities of the management in an advisory capacity.

Discovering Investor Relations

More ESG topics

Back to top expand_less